Shares of MetLife, Inc. (NYSE:MET - Get Free Report) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $65.21 and last traded at $66.11, with a volume of 381798 shares traded. The stock had previously closed at $69.07.
Analyst Upgrades and Downgrades
MET has been the subject of a number of research analyst reports. Barclays cut their target price on shares of MetLife from $95.00 to $88.00 and set an "overweight" rating for the company in a research report on Friday. Keefe, Bruyette & Woods reduced their price objective on MetLife from $98.00 to $95.00 and set an "outperform" rating for the company in a research report on Wednesday. JPMorgan Chase & Co. dropped their target price on MetLife from $88.00 to $86.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 2nd. UBS Group upped their price target on shares of MetLife from $94.00 to $98.00 and gave the company a "buy" rating in a research report on Wednesday, April 2nd. Finally, BMO Capital Markets began coverage on shares of MetLife in a report on Thursday, January 23rd. They issued a "market perform" rating and a $97.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $92.46.
Get Our Latest Analysis on MET
MetLife Stock Performance
The company has a market cap of $48.54 billion, a PE ratio of 11.94, a PEG ratio of 0.65 and a beta of 0.89. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The business's 50 day moving average is $80.32 and its two-hundred day moving average is $82.46.
MetLife (NYSE:MET - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, equities research analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current year.
Institutional Investors Weigh In On MetLife
Several institutional investors and hedge funds have recently modified their holdings of MET. Procyon Advisors LLC boosted its position in shares of MetLife by 9.6% during the first quarter. Procyon Advisors LLC now owns 38,691 shares of the financial services provider's stock worth $3,106,000 after acquiring an additional 3,379 shares during the last quarter. Curat Global LLC purchased a new stake in MetLife in the 1st quarter worth $916,000. Vest Financial LLC boosted its holdings in shares of MetLife by 73.5% during the 1st quarter. Vest Financial LLC now owns 27,161 shares of the financial services provider's stock valued at $2,181,000 after purchasing an additional 11,507 shares during the last quarter. Chesley Taft & Associates LLC grew its position in shares of MetLife by 6.6% during the first quarter. Chesley Taft & Associates LLC now owns 19,028 shares of the financial services provider's stock valued at $1,528,000 after purchasing an additional 1,180 shares in the last quarter. Finally, Portside Wealth Group LLC increased its holdings in shares of MetLife by 3.9% in the first quarter. Portside Wealth Group LLC now owns 11,689 shares of the financial services provider's stock worth $957,000 after purchasing an additional 444 shares during the last quarter. Institutional investors own 94.99% of the company's stock.
MetLife Company Profile
(
Get Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.